cURL Error: 0 Business Wire – Página 23 – International World Of Business

Alchemy Secures $6M to Scale Global Defence and Automotive Innovations

New funding will drive defence and automotive innovation, expand Canadian manufacturing, and support international growth KITCHENER,…

HelloFresh Reaffirms Commitment to Fighting Food Insecurity During Hunger Action Month

HelloFresh and its partners celebrate 10 million meals donated through Meals with Meaning, a program launched…

1Kosmos Wins 2025 SiliconANGLE TechForward Award for Identity Verification

Platform recognized for helping enterprises stop identity fraud during onboarding and account recovery, while providing phishing-resistant…

Saint Kate – The Arts Hotel Unveils The Studio Kitchen & Cocktails

Designed to be Milwaukee’s Hub for Inspired Dining and Social Gathering, The Studio Delivers an Experience…

Zenity Unveils Full Agenda for AI Agent Security Summit 2025 in San Francisco

Industry Leaders from Electronic Arts, Exabeam, Google, OpenAI, ServiceNow, Slalom, Stanford University, Walmart to Present on…

T-Mobile Tops $19M in Hometown Grants, Empowering 425 Local Communities Nationwide

With 25 new recipients, America’s best network continues its mission to strengthen small towns across the…

Snowflake Named 2025 Strategic Partner of the Year by Morgan Stanley

Morgan Stanley’s seven-year strategic relationship with Snowflake propels innovation for the Firm, while upholding robust standards…

Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people…

Diality Announces First Patient Treated in Moda-flx Home IDE PRESCRIBE Diality Clinical Trial

IRVINE, Calif.–(BUSINESS WIRE)–#clinicaltrials—Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today…

PureTech Founded Entity Seaport Therapeutics Advances Second Therapeutic Candidate into Clinical Development with Dosing of First Participant in Phase 1 Study of GlyphAgo™ (SPT-320) in Healthy Volunteers

GlyphAgo is an oral prodrug of agomelatine, a medicine with established clinical efficacy in generalized anxiety…